<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366267">
  <stage>Registered</stage>
  <submitdate>5/05/2014</submitdate>
  <approvaldate>17/06/2014</approvaldate>
  <actrnumber>ACTRN12614000638639</actrnumber>
  <trial_identification>
    <studytitle>Perfusion index as a predictor for optimum positive end -expiratory pressure in Acute  Respiratory Distress Syndrome patients management </studytitle>
    <scientifictitle>Perfusion index as a predictor for optimum positive end-expiratory pressure(PEEP) in acute respiratory distress syndrome(ARDS) patients management </scientifictitle>
    <utrn>U1111-1156-3719</utrn>
    <trialacronym>Pip ops</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>We will study the relation between perfusion index  and optimum PEEP in Acute respiratory distress syndrome(ARDS) patients</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>We will titrate the PEEP level from baseline(5cm.H2O) by increments of 2cm.H2O for 30 minutes  for each PEEP level till reaching the value of optimum PEEP that corresponds to best oxygenation(Pao2-sao2 and hypoxic index ) and correlates  it with the perfusion index changes in ARDS patients.</interventions>
    <comparator>No control group.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Optimum PEEP  in ARDS  patients. tools used include hemodynamic parameters(MAP-C.V.P.) ,oxygenation parameters(Pao2-sao2-hypoxic index{pao2/fio2} )-static compliance- dead space to tidal volue ratio(Vd/Vt).</outcome>
      <timepoint>6 hours after confirmation of ARDS diagnosis</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ARDS patients due to pulmonary causes (eg severe pneumonia).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Extra pulmonary causes of ARDS, pneumothorax, coagulapathy CHF , cardiogenic pulmonary edema, hemodynamics instability.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Data are presented as median , range values . paired T. test will be used. Sample size , according to the survey system software.we assumed confidence level of 95% at appropriate confidence interval to detect 15% difference in perfusion index ,the sample size of total 20 cases was calculated(www.surveysystem.com).</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>5/05/2014</anticipatedstartdate>
    <actualstartdate>5/05/2014</actualstartdate>
    <anticipatedenddate>5/12/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Qena</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>South valley university</primarysponsorname>
    <primarysponsoraddress>Qena Egypt postal code 85823</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>South valley university</fundingname>
      <fundingaddress>South valley university , Qena , postal code 85823</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress>Nil</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We will study the relation between perfusion index and optimum positive end expiratory pressure in Acute respiratory distress syndrome  patients  management.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Qena faculty of medicine ethics commitee</ethicname>
      <ethicaddress>Qena- south valley university-postal code 85823-in front of south valley university hotel-Egypt.</ethicaddress>
      <ethicapprovaldate>5/05/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>5/05/2014</ethicsubmitdate>
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Hatem saber Mohamed-south valley university.</name>
      <address>South valley university- Qena faculty of medicine-postal code 85823-Qena.</address>
      <phone>+201005257062</phone>
      <fax />
      <email>Dr.hatem_saber@hotmail.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Salah mostafa asida-south valley university.</name>
      <address>South valley university- Qena faculty of medicine-postal code 85823-Qena.</address>
      <phone>+201005262075</phone>
      <fax />
      <email>Salasida59@gmail.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Salah asida-south valley university.</name>
      <address>South valley university- Qena faculty of medicine-postal code 85823-Qena.</address>
      <phone>+201005262075</phone>
      <fax />
      <email>Salasida59@gmail.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Hatem saber mohamed</name>
      <address>Qena faculty of medicine- postal code 85823-Qena.</address>
      <phone>+201005257062</phone>
      <fax />
      <email>dr.hatem_saber@hotmail.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>